Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company
Clinical trials sponsored by Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company, explained in plain language.
-
Experimental drug targets tough cancers in early trial
Disease control CompletedThis early-phase study tested an experimental drug called DCR-STAT3 in 26 adults with advanced solid tumors that no longer responded to standard treatments. The main goal was to check the drug's safety and how the body processes it. Researchers gave increasing doses to find the b…
Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 17, 2026 03:13 UTC
-
Promising drug for rare kidney disease tested in young kids
Disease control CompletedThis study tested a drug called nedosiran in 27 children from birth to 11 years old who have primary hyperoxaluria, a rare condition that causes high oxalate levels and can damage kidneys. The goal was to see if the drug safely lowers oxalate in the urine. Results showed it helpe…
Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New Alcohol-Use drug passes early safety check in healthy drinkers
Symptom relief CompletedThis early-stage study tested a new drug called DCR-AUD in 16 healthy adults who drink alcohol socially. The main goal was to see if repeat doses are safe and how the drug works in the body. Participants received either the drug or a placebo and had up to 10 alcohol interaction s…
Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Symptom relief
Last updated Jun 09, 2026 12:06 UTC